SAN FRANCISCO -- For patients with recurrent prostate cancer, those with a certain subtype had clinically meaningful benefits ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

A significant proportion of men with elevated prostate-specific antigen levels see their values drop below biopsy thresholds ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...

The PSA test is often paired with a digital rectal exam (DRE), where a doctor inserts their finger into the rectum to feel ...

Use of PSMA PET/CT imaging before salvage radiotherapy was linked to improved survival for patients with BCR prostate cancer ...

Declines in prostate-specific antigen (PSA) level after treatment with the next-generation androgen receptor inhibitor drug enzalutamide predict improved survival rates in men with non-metastatic ...

In honor of Prostate Cancer Awareness Month in September, Cleveland Diagnostics has proudly relaunched its PSA on PSA ...

Please provide your email address to receive an email when new articles are posted on . At any given PSA level, Black men are more likely than white men to harbor prostate cancer, according to ...

September is Prostate Cancer Awareness Month. Mississippi has one of the highest prostate cancer mortality rates in the ...

Prostate cancer was found in 23% of men whose initially abnormal PSA levels fell to below 4 ng/mL. Men whose PSA levels rise above 4 ng/mL—a commonly used threshold for prostate biopsy—but then ...

− Post-hoc analysis from Blue Earth Diagnostics’ Phase 3 SPOTLIGHT trial provides data about treatment planning, particularly when curative salvage therapy is considered – MONROE TOWNSHIP, N.J. & ...